Digital Media Net - Your Gateway To Digital media Creation. News and information on Digital Video, VR, Animation, Visual Effects, Mac Based media. Post Production, CAD, Sound and Music
Categories: News

TorHoerman Law Announces $495 Million Jury Verdict in Case Involving Abbott Laboratories

A Missouri jury awarded damages following claims related to infant formula and necrotizing enterocolitis (NEC), according to court proceedings.

ST. LOUIS, MO / ACCESS Newswire / January 16, 2026 / TorHoerman Law, a national injury litigation law firm, announced that a Missouri jury has awarded a total verdict of $495 million in a lawsuit involving Abbott Laboratories, the manufacturer of Similac infant formula, following a trial concerning claims of necrotizing enterocolitis (NEC) in a premature infant.

According to court records, the lawsuit was brought by Margo Gill on behalf of her daughter, Robynn Gill, who was born prematurely and later developed NEC after being fed a cow’s milk-based infant formula product identified during trial proceedings.

Case Background

NEC is a serious gastrointestinal condition that primarily affects premature infants. Medical experts have reported that the condition can lead to severe complications requiring long-term medical care.

During the trial, evidence was presented regarding the infant’s medical condition and the alleged association between cow’s milk-based formula and NEC in premature infants. Testimony detailed the extensive medical interventions required following the diagnosis.

Jury Verdict

After hearing the evidence, the jury returned a verdict totaling $495 million, which included:

  • $95 million in compensatory damages intended to address medical care, long-term treatment, and related losses

  • $400 million in punitive damages, as determined by the jury

A representative from TorHoerman Law stated, “This verdict reflects the jury’s findings based on the evidence presented during trial.”

Legal Significance

The case is one of several lawsuits nationwide addressing claims related to infant formula and NEC. Court proceedings such as this continue to shape how product liability claims in the neonatal care space are evaluated by juries.

About TorHoerman Law

TorHoerman Law is a nationally recognized injury litigation law firm with experience in product liability, complex litigation, and catastrophic injury cases. The firm has handled thousands of cases over the past 25 years.

For more information, visit https://www.torhoermanlaw.com.

Media Contact:
TorHoerman Law
(888) 508-6752
info@thlawyer.com
https://www.torhoermanlaw.com/

SOURCE: TorHoerman Law

View the original press release on ACCESS Newswire

Staff

Recent Posts

GameSquare to Present at the Sequire Investor Summit on January 20-22, 2026

FRISCO, TEXAS / ACCESS Newswire / January 16, 2026 / GameSquare Holdings, Inc. ("GameSquare" or…

2 hours ago

CCL Industries Signs Agreement to Acquire ALT Technologies for CCL Design

TORONTO, ON / ACCESS Newswire / January 16, 2026 / CCL Industries Inc., (TSX:CCL.A)(TSX:CCL.B) a…

2 hours ago

Targeted Lending Co., LLC Expands Senior Credit Facility with Wells Fargo Capital Finance to $125 Million

BUFFALO, NEW YORK / ACCESS Newswire / January 16, 2026 / Targeted Lending Co., LLC,…

2 hours ago

Club Car Wash Celebrates New Site in Denton, Texas, with Giveaway and Deals

Get $1 MVP Washes - All Proceeds Donated to Serve Denton DENTON, TEXAS / ACCESS…

2 hours ago

Twin Vee PowerCats Co. to Host Strategic Corporate Update Event for Investors, Analysts, and Media

Conference Call to be held Wednesday, January 21, 2026 at 10:00 a.m. Eastern Time FORT…

2 hours ago

Ondas Hosts OAS Investor Day: Ups 2026 Revenue Target to $170 – $180 Million

OAS Investor Day to be conducted today, January 16, 2026 at 10:00 AM ETPreliminary 2025…

2 hours ago